AI news ·
Stryker plans $400M investment in CMR Surgical robotics
Stryker is investing $400 million in CMR Surgical and will become the exclusive U.S. sales agent for its Versius surgical robot.

Stryker has disclosed plans for a preferred-equity investment in CMR Surgical, a move that will also make Stryker the exclusive U.S. sales agent for the Versius surgical-robot portfolio. The transaction is valued at $400 million.
The agreement points to ongoing consolidation in the market for AI-enabled medical robotics. Completion of the deal is contingent on regulatory approval and successful clinical adoption of the Versius system.
Source: https://dailyaibrief.com